358 related articles for article (PubMed ID: 30635792)
21. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
22. TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.
Bunai K; Okubo H; Hano K; Inoue K; Kito Y; Saigo C; Shibata T; Takeuchi T
J Cell Mol Med; 2018 Feb; 22(2):1026-1033. PubMed ID: 29164763
[TBL] [Abstract][Full Text] [Related]
23. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
[TBL] [Abstract][Full Text] [Related]
24. Involvement of RNase 7 in the malignant potential of oral squamous cell carcinoma cells.
Neopane P; Kurashige Y; Yoshida K; Uehara O; Paudel D; Morikawa T; Sato J; Saitoh M; Abiko Y
Oncol Rep; 2020 Sep; 44(3):1216-1223. PubMed ID: 32705284
[TBL] [Abstract][Full Text] [Related]
25. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
[TBL] [Abstract][Full Text] [Related]
26. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
27. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
28. Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Arimoto S; Hasegawa T; Takeda D; Saito I; Amano R; Akashi M; Komori T
Anticancer Res; 2018 Nov; 38(11):6157-6162. PubMed ID: 30396932
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
30. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
31. Aberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCC.
Fan H; Tian H; Cheng X; Chen Y; Liang S; Zhang Z; Liao Y; Xu P
J Cell Physiol; 2020 Feb; 235(2):1850-1865. PubMed ID: 31338836
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
Yang Y; Chen D; Liu H; Yang K
Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
[TBL] [Abstract][Full Text] [Related]
33. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of Bcl-2 in oral epithelial dysplasia and oral squamous cell carcinoma.
Juneja S; Chaitanya NB; Agarwal M
Indian J Cancer; 2015; 52(4):505-10. PubMed ID: 26960459
[TBL] [Abstract][Full Text] [Related]
35. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
[TBL] [Abstract][Full Text] [Related]
36. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
Dai J; Wei W
Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
[TBL] [Abstract][Full Text] [Related]
37. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
[TBL] [Abstract][Full Text] [Related]
38. Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance.
Schiegnitz E; Kämmerer PW; Rode K; Schorn T; Brieger J; Al-Nawas B
J Oral Pathol Med; 2016 Jan; 45(1):63-9. PubMed ID: 25880686
[TBL] [Abstract][Full Text] [Related]
39. Decreased cytoplasmic X-box binding protein-1 expression is associated with poor prognosis and overall survival in patients with oral squamous cell carcinoma.
Hsu HT; Hsing MT; Yeh CM; Chen CJ; Yang JS; Yeh KT
Clin Chim Acta; 2018 Apr; 479():66-71. PubMed ID: 29305191
[TBL] [Abstract][Full Text] [Related]
40. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
Zhang J; Ling T; Wu H; Wang K
J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
